Eva Bilange

Eva Bilange is an experienced professional in investor relations and corporate communications, currently serving as Manager of Investor Relations & Corporate Communications at 89bio since July 2025. Prior to this role, Eva held various positions at Cytokinetics from November 2020 to July 2025, progressing from Coordinator to Manager in the same field. Eva also gained marketing experience as a Marketing Intern at Apeel and worked as an Investor Relations Intern at Ionis Pharmaceuticals, Inc. in the summer of 2019. Eva earned a B.A. in Communication with minors in Applied Psychology and Technology Management from UC Santa Barbara.